92 related articles for article (PubMed ID: 6483219)
1. [Curve of plasma disappearance of bromosulfophthalein after a single injection. Control of cirrhosis patients after elective portosystemic derivation].
Zotti S; Turrin M; Gerunda G; Maffei Faccioli A; Ghidini O
Minerva Chir; 1984 Jun; 39(11):887-96. PubMed ID: 6483219
[No Abstract] [Full Text] [Related]
2. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.
Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M
Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113
[TBL] [Abstract][Full Text] [Related]
3. Lack of increase in insulin resistance after portosystemic surgical shunt in patients with cirrhosis.
Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Pagano G; Robecchi A
N Engl J Med; 1985 Jun; 312(26):1709-10. PubMed ID: 4000220
[No Abstract] [Full Text] [Related]
4. Liver transplantation in patients with a previous portasystemic shunt.
Moreno-González E; Gomez R; Bonet H; Garcia I; Gonzalez-Pinto I; Loinaz C; Maffettone V
Hepatogastroenterology; 1993 Dec; 40(6):593-5. PubMed ID: 8119646
[TBL] [Abstract][Full Text] [Related]
5. Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
Dell'Era A; Grande L; Barros-Schelotto P; Turnes J; Fuster J; Charco R; García-Valdecasas JC; Bosch J; García-Pagán JC
Surgery; 2005 Jun; 137(6):620-5. PubMed ID: 15933628
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation.
Lerut J; Goffette P; Laterre PF; Donataccio M; Reynaert MS; Otte JB
Hepatogastroenterology; 1995; 42(6):985-7. PubMed ID: 8847056
[TBL] [Abstract][Full Text] [Related]
7. Changing pattern of portasystemic shunt surgery.
van der Vliet JA; de Visser E; Buskens FG
Eur J Surg; 1995 Dec; 161(12):877-80. PubMed ID: 8775628
[TBL] [Abstract][Full Text] [Related]
8. [Portosystemic shunts in the treatment of bleeding esophageal varices in cirrhotic patients: between sclerotherapy and transplantation].
Gozzetti G; Cavallari A; Mazziotti A; Recordare A; Bellusci R; Nardo B; De Raffele E; Vivarelli M; Camillò B
Minerva Chir; 1996 Nov; 51(11):887-95. PubMed ID: 9072715
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of patients with liver cirrhosis and portal hypertension syndrome].
Khamidov PM; Riabukhin IA
Khirurgiia (Mosk); 1983 Jul; (7):73-6. PubMed ID: 6620915
[No Abstract] [Full Text] [Related]
10. Cerebral edema and hyperammonemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient.
Kavitt RT; Yang VL; Jensen DM
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1054-6. PubMed ID: 18603480
[TBL] [Abstract][Full Text] [Related]
11. [Some pathogenetic aspects of developing liver failure and preventing it in patients with liver cirrhosis after portosystemic shunting].
Nazyrov FG; Akilov KhA; Ibadov RA; Asabaev ASh; Zaĭnutdinov UI; Khafizov BB
Vestn Khir Im I I Grek; 2002; 161(1):87-90. PubMed ID: 12048797
[TBL] [Abstract][Full Text] [Related]
12. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial.
Sauer P; Theilmann L; Herrmann S; Bruckner T; Roeren T; Richter G; Stremmel W; Stiehl A
Hepatology; 1996 Dec; 24(6):1433-6. PubMed ID: 8938176
[TBL] [Abstract][Full Text] [Related]
13. [Transjugular intrahepatic portasystemic stent shunt (TIPSS). Results and complications].
Theilmann L; Sauer P
Radiologe; 1994 Apr; 34(4):174-7. PubMed ID: 8052708
[TBL] [Abstract][Full Text] [Related]
14. [Sulfobromophthalein clearance and survival of cirrhotics after an elective porto-systemic shunt].
Spina GP; Galeotti F; Sorato R; Maffei-Faccioli A; Zotti S; Ghidini O
Minerva Chir; 1980 Feb; 35(3):135-42. PubMed ID: 7374971
[TBL] [Abstract][Full Text] [Related]
15. [The clinical efficacy and complications of the transjugular intrahepatic portosystemic shunt-stent].
Santolaria Piedrafita S; Salvador Milian E; Barrao Yoldi E; Ducons García J; Oscariz Gonzálvez J; Ariño Calve I; Fernández Gómez J; de Gregorio Ariza MA; Barrao Comps F
Rev Clin Esp; 1995 Sep; 195(9):609-13. PubMed ID: 7481003
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
17. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
18. Role of surgical portosystemic shunts in the era of interventional radiology and liver transplantation.
Orug T; Soonawalla ZF; Tekin K; Olliff SP; Buckels JA; Mayer AD
Br J Surg; 2004 Jun; 91(6):769-73. PubMed ID: 15164449
[TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals.
Herrero JI; Bilbao JI; Diaz ML; Alegre F; Inarrairaegui M; Pardo F; Quiroga J
Liver Transpl; 2009 Jan; 15(1):111-4. PubMed ID: 19109845
[No Abstract] [Full Text] [Related]
20. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis.
Schölmerich J; Becher MS; Köttgen E; Rauch N; Häussinger D; Löhle E; Vuilleumier JP; Gerok W
Hepatogastroenterology; 1983 Aug; 30(4):143-7. PubMed ID: 6685108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
